NASDAQ:ATRA
Atara Biotherapeutics Stock News
$0.546
-0.0197 (-3.48%)
At Close: May 09, 2024
Why Atara Biotherapeutics (ATRA) Stock Might be a Great Pick
01:21pm, Wednesday, 13'th May 2020
Atara Biotherapeutics (ATRA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
JP Morgan Maintains Neutral on Atara Biotherapeutics, Raises Price Target to $23
12:00am, Tuesday, 12'th May 2020Atara Biotherapeutics Announces Appointment of Cell & Gene Therapy Expert Maria Grazia Roncarolo, MD to Board of Directors
08:01pm, Monday, 11'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Equity Residential, Fiserv
06:02pm, Monday, 11'th May 2020
Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Acushnet Holdings, Equity Residential and Fiserv, on
Monday.
HIGHLIGHTS
Will Atara Biotherapeutics Continue to Surge Higher?
03:25pm, Monday, 11'th May 2020
As of late, it has definitely been a great time to be an investor Atara Biotherapeutics
Atara Biotherapeutics Announces Appointment of Cell & Gene Therapy Expert Maria Grazia Roncarolo, MD to Board of Directors
12:00am, Monday, 11'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transform
Edited Transcript of ATRA earnings conference call or presentation 6-May-20 8:30pm GMT
08:12am, Friday, 08'th May 2020
Q1 2020 Atara Biotherapeutics Inc Earnings Call
Noble Energy Announces First Quarter Results
12:00am, Friday, 08'th May 2020
Noble Energy, Inc. (NASDAQ: NBL) (“Noble Energy” or the “Company”) today provided first quarter financial and operating results. First quarter highlig
Atara Biotherapeutics Inc (ATRA) Q1 2020 Earnings Call Transcript
06:00pm, Thursday, 07'th May 2020
Ladies and gentlemen, thank you for standing by, and welcome to the Atara Biotherapeutics First Quarter 2020 Financial Results Conference Call. Thank you, Eric, and thanks to all of you for joining u
Edited Transcript of ATRA earnings conference call or presentation 6-May-20 8:30pm GMT
11:29am, Thursday, 07'th May 2020
Q1 2020 Atara Biotherapeutics Inc Earnings Call
Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q1 2020 Results - Earnings Call Transcript
03:23am, Thursday, 07'th May 2020
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q1 2020 Results Conference Call May 06, 2020 04:30 PM ET Company Participants Eric Hyllengren - Vice President of Inve
Atara Biotherapeutics Announces First Quarter 2020 Financial Results and Operational Progress
08:01pm, Wednesday, 06'th May 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Reviewing Neon Therapeutics (NASDAQ:NTGN) & Atara Biotherapeutics (NASDAQ:ATRA)
09:20am, Saturday, 02'nd May 2020
Neon Therapeutics (NASDAQ:NTGN) and Atara Biotherapeutics (NASDAQ:ATRA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the streng
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and Dynavax (DVAX)
03:50pm, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin Pharmaceutical (BMRN) and Dynavax (DVAX) with
